CUSIP: 817763105
Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
32,465,314
-
Share change
-
-1,583,338
-
Total reported value
-
$19,785,532
-
Put/Call ratio
-
106%
-
Price per share
-
$0.61
-
Number of holders
-
64
-
Value change
-
-$819,195
-
Number of buys
-
22
-
Number of sells
-
33
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2023
-
Previous quarter:
Q3 2022
Recent filing periods for CUSIP 817763105:
Institutional Holders of SESEN BIO INC - COM (SESN) as of Q4 2022
As of 31 Dec 2022,
SESEN BIO INC - COM (SESN) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,465,314 shares.
The largest 10 holders included
VANGUARD GROUP INC, BML Capital Management, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, BLODGETT WEALTH ADVISORS, LLC, ACADIAN ASSET MANAGEMENT LLC, and MORGAN STANLEY.
This page lists
64
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.